CTOs on the Move

delta flex travelers

www.flextravelers.com

 
delta flex travelers is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Monell Chemical Senses Center

Monell Chemical Senses Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Monell Chemical Senses Center is based in Philadelphia, PA. You can find more information on Monell Chemical Senses Center at www.monell.org

HMA Inc

HMA Inc is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dark Heart Nursery

Since 2007, Dark Heart Nursery has specialized in cultivating high quality clones for growers across Northern California.   Our years of experience allow us to bring you consistently premium clones from both popular and emerging genetic lines that will perform well in a variety of settings. We take pride in our work and continually adapt our process and selection to meet the diverse needs of growers large and small.

Curo Health Services

At Curo, we are committed to clinical excellence and integrity, insuring our patients the highest quality of care and comfort. To maintain this commitment we hire only the most experienced and capable hospice and home health care professionals. Our clinical team members are experts in pain and symptom management, and our support team members are skilled in the specific issues of emotional support, spiritual counseling, and resource referral.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.